Floatz logo

67 assets in Colorectal Adenocarcinoma

Therapeutic assets addressing Colorectal Adenocarcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Regorafenib
Colorectal Adenocarcinoma
City of Hope Medical CenterP2BB (67)
Trifluridine
Colorectal Adenocarcinoma
Centre Hospitalier Universitaire DijonP3BB (67)
Balstilimab
Colorectal Adenocarcinoma
City of Hope Medical CenterP2BB (66)
Botensilimab
Colorectal Adenocarcinoma
City of Hope Medical CenterP2BB (66)
Cetuximab
Colorectal Adenocarcinoma
BayerP2BB (64)
Fluorouracilum
Colorectal Adenocarcinoma
Centre Hospitalier Universitaire DijonP3BB (64)
Tipiracil
Colorectal Adenocarcinoma
Academic and Community Cancer Research UnitedP2BB (64)
Capecitabine
Colorectal Adenocarcinoma
Gruppo Oncologico del Nord-OvestP3B (63)
Irinotecan
Colorectal Adenocarcinoma
Centre Hospitalier Universitaire DijonP3B (63)
Nivolumab
Colorectal Adenocarcinoma
University Hospital, AkershusP2B (63)
Oxaliplatin
Colorectal Adenocarcinoma
PfizerP3B (62)
Panitumumab
Colorectal Adenocarcinoma
Academic and Community Cancer Research UnitedP3B (59)
Pembrolizumab
Colorectal Adenocarcinoma
Salubris Biotherapeutics IncP2B (59)
Cis-Diamminedichloroplatinum Ii
Colorectal Adenocarcinoma
AkesoP2B (58)
Fludarabine
Colorectal Adenocarcinoma
Beijing BiotechP2B (58)
Atezolizumab
Colorectal Adenocarcinoma
National Cancer Institute (NCI)P3B (57)
Encorafenib
Colorectal Adenocarcinoma
National Cancer Institute (NCI)P2B (57)
Trastuzumab
Colorectal Adenocarcinoma
Academic and Community Cancer Research UnitedP2B (57)
Tucatinib
Colorectal Adenocarcinoma
Academic and Community Cancer Research UnitedP2B (57)
Ivonescimab
Colorectal Adenocarcinoma
AkesoP3CCC (54)
Sirexatamab
Colorectal Adenocarcinoma
Leap Therapeutics, Inc.P2CCC (54)
Fruquintinib
Colorectal Adenocarcinoma
Barbara Ann Karmanos Cancer InstituteP2CCC (53)
Neomycin
Colorectal Adenocarcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Trametinib
Colorectal Adenocarcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Vancomycin
Colorectal Adenocarcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Vandazole
Colorectal Adenocarcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Adenovirus 5/F35-Human Guanylyl Cyclase C-Padre
Colorectal Adenocarcinoma
Thomas Jefferson UniversityP2CCC (51)
Cabozantinib
Colorectal Adenocarcinoma
University of Colorado, DenverP2CCC (51)
Human Adenovirus C Serotype 5
Colorectal Adenocarcinoma
Thomas Jefferson UniversityP2CCC (51)
Tislelizumab
Colorectal Adenocarcinoma
SOLTI Breast Cancer Research GroupP2CCC (51)
Trastuzumab Deruxtecan
Colorectal Adenocarcinoma
Gruppo Oncologico del Nord-OvestP2CCC (51)
Carboplatin
Colorectal Adenocarcinoma
AkesoP1/2CCC (48)
Rintatolimod
Colorectal Adenocarcinoma
Roswell Park Cancer InstituteP2CCC (48)
Docetaxel
Colorectal Adenocarcinoma
AkesoP1/2CC (46)
Spartalizumab
Colorectal Adenocarcinoma
SOLTI Breast Cancer Research GroupP2CC (46)
Eb-Duo-Car-Nk-Cea/Gcc
Colorectal Adenocarcinoma
Beijing BiotechP1/2CC (45)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
Colorectal Adenocarcinoma
National Cancer Institute (NCI)P1/2CC (45)
Pidnarulex
Colorectal Adenocarcinoma
National Cancer Institute (NCI)P1/2CC (45)
Polypepi1018
Colorectal Adenocarcinoma
Mayo ClinicP1CC (44)
a2b395
Colorectal Adenocarcinoma
A2 Biotherapeutics Inc.P1/2CC (43)
a2b530
Colorectal Adenocarcinoma
A2 Biotherapeutics Inc.P1/2CC (43)
a2b543
Colorectal Adenocarcinoma
A2 Biotherapeutics Inc.P1/2CC (43)
a2b694
Colorectal Adenocarcinoma
A2 Biotherapeutics Inc.P1/2CC (43)
ak129
Colorectal Adenocarcinoma
AkesoP1/2CC (43)
Avutometinib
Colorectal Adenocarcinoma
University of ChicagoP1/2CC (43)
Fosifloxuridine Nafalbenamide
Colorectal Adenocarcinoma
NuCana plcP2CC (43)
jk08
Colorectal Adenocarcinoma
Salubris Biotherapeutics IncP1/2CC (43)
Lenvatinib
Colorectal Adenocarcinoma
Salubris Biotherapeutics IncP1/2CC (43)
Penpulimab
Colorectal Adenocarcinoma
AkesoP1/2CC (43)
tst003
Colorectal Adenocarcinoma
Suzhou Transcenta Therapeutics Co., Ltd.P1/2CC (43)
Showing 1 to 50 of 67 assets
PreviousPage 1 of 2Next